Directed new share issue in Wilson Therapeutics AB (SE) — SEK 244 million

Carnegie acted as joint bookrunner in the directed new share issue of 2,572,024 million new shares at a subscription price of SEK 95.00 per share. Wilson Therapeutics is a biopharmaceutical company that develops novel therapies for patients with rare diseases. December 2017.